Paper Details

  1. Home
  2. Paper Details

A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis.

Author: CarrascoRoberto, CasasAlberto, DiazMaria E, FalconMayer, FelixEfraín, FloresMónica, GuerraFrances, IbericoCarlos, ReyesIsabel, Sanchez-GambettaSergio, de Los RíosJorge

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.

Overview

The combination of sulfamethoxazole, trimethoprim, and guaifenesin (STG) was generally safe in both pediatric and adult patients with acute bronchitis. Further research is needed to evaluate the safety and efficacy of STG in these populations.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: This exploratory study assessed the safety of the combination of sulfamethoxazole, trimethoprim and guaifenesin (STG) in adult and pediatric patients with acute bronchitis according to local labelling in Peru. RESULTS: We enrolled 51 pediatric and 52 adult participants diagnosed with acu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399863/

データ提供：米国国立医学図書館（NLM）

A Pilot Study: Assessing the Safety of Sulfamethoxazole, Trimethoprim, and Guaifenesin

The world of medicine is constantly striving for safety and effectiveness in treating various ailments. This pilot study delves into the safety of a drug combination commonly used to treat acute bronchitis. The researchers investigated the safety of sulfamethoxazole, trimethoprim, and guaifenesin (STG) in both pediatric and adult patients. They collected data on adverse events and analyzed the results to assess the potential risks associated with this drug combination. While the study findings suggest a generally good safety profile for STG, the authors emphasize the need for further research to establish definitive conclusions about its safety and efficacy.

A Journey of Discovery in Drug Safety

This pilot study serves as a crucial step in understanding the safety of STG for treating acute bronchitis. The researchers have provided valuable insights, highlighting the need for further research to confirm the safety of this drug combination. Such studies are like explorers traversing the vast desert, seeking new knowledge and understanding to guide clinical practice.

Navigating the Sands of Information

Just as a camel navigates the desert landscape, physicians and researchers must carefully navigate the sands of information to make informed decisions. This study offers a preliminary glimpse into the safety of STG, but further investigation is crucial to ensure the best possible outcomes for patients. It's important to stay informed about the latest research and consult with healthcare professionals to make the most appropriate treatment decisions.

Dr.Camel's Conclusion

This pilot study provides a starting point for understanding the safety of STG in treating acute bronchitis. While the results are promising, more research is needed to confirm its safety and efficacy. The authors have embarked on a journey of discovery, and their findings serve as a valuable guide for future research and clinical practice.

Date :
  1. Date Completed 2019-06-10
  2. Date Revised 2023-10-06
Further Info :

Pubmed ID

30832720

DOI: Digital Object Identifier

PMC6399863

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.